China: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in China

In 2022, the Chinese medicaments containing corticosteroid hormones market decreased by X% to $X, falling for the second consecutive year after two years of growth. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Medicaments containing corticosteroid hormones consumption peaked at $X in 2020; afterwards, it flattened through to 2022.

Production of Medicaments Containing Corticosteroid Hormones in China

In value terms, medicaments containing corticosteroid hormones production amounted to $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2015 with an increase of X%. As a result, production attained the peak level of $X; afterwards, it flattened through to 2022.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Medicaments Containing Corticosteroid Hormones

Exports from China

In 2022, medicaments containing corticosteroid hormones exports from China soared to X tons, with an increase of X% on the previous year. Over the period under review, total exports indicated a strong increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2018 indices. The most prominent rate of growth was recorded in 2017 with an increase of X% against the previous year. The exports peaked in 2022 and are likely to see gradual growth in the near future.

In value terms, medicaments containing corticosteroid hormones exports skyrocketed to $X in 2022. Overall, exports continue to indicate a significant expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

France (X tons) was the main destination for medicaments containing corticosteroid hormones exports from China, accounting for a X% share of total exports. Moreover, medicaments containing corticosteroid hormones exports to France exceeded the volume sent to the second major destination, Brazil (X tons), twofold. Myanmar (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual growth rate of volume to France amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Brazil (X% per year) and Myanmar (X% per year).

In value terms, the largest markets for medicaments containing corticosteroid hormones exported from China were France ($X), Denmark ($X) and Italy ($X), with a combined X% share of total exports.

In terms of the main countries of destination, Denmark, with a CAGR of X%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average medicaments containing corticosteroid hormones export price amounted to $X per ton, picking up by X% against the previous year. Over the period under review, the export price recorded buoyant growth. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Hong Kong SAR ($X per ton), while the average price for exports to Peru ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Hong Kong SAR (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into China

For the fifth consecutive year, China recorded growth in overseas purchases of medicaments containing corticosteroid hormones, which increased by X% to X tons in 2022. Over the period under review, imports enjoyed a prominent expansion. The pace of growth appeared the most rapid in 2016 when imports increased by X% against the previous year. Imports peaked in 2022 and are likely to continue growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones imports reached $X in 2022. In general, imports saw a buoyant increase. The most prominent rate of growth was recorded in 2017 when imports increased by X%. Imports peaked in 2022 and are likely to see steady growth in the near future.

Imports by Country

France (X tons), Germany (X tons) and Australia (X tons) were the main suppliers of medicaments containing corticosteroid hormones imports to China, with a combined X% share of total imports. Sweden, Spain, Italy, Belgium, Denmark, the UK, Hong Kong SAR and Switzerland lagged somewhat behind, together comprising a further X%.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Denmark (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones suppliers to China were Germany ($X), France ($X) and Denmark ($X), with a combined X% share of total imports.

Denmark, with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average medicaments containing corticosteroid hormones import price amounted to $X per ton, rising by X% against the previous year. Overall, the import price showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 when the average import price increased by X% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2014; however, from 2015 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Switzerland ($X,139 per ton), while the price for Hong Kong SAR ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :